Call Now For Assistance: (800) 799-1911
OmniTrace Corp. was founded in 2001 and has since developed into a global provider of Lost to Follow-Up clinical trial support services. OmniTrace provides our services to a global clientele of clinical trial sponsors, contract research organizations, academic institutions, National Institutes of Health, study sites and hospitals.
Our nationwide network of researchers, investigators and genealogists, combined with a sophisticated computer and database system, allows us to locate patients anywhere in the world.
OmniTrace will customize our patient locate program to your requirements.
Find patients anywhere
Call Us Now 800-799-1911 or Complete Our Form for Clinical Trial Assistance.
The OmniTrace Solution – A Comprehensive Approach to Locating Missing Patients in Clinical Trials
At OmniTrace Corp., we understand the challenges that CROs, pharmaceutical companies and clinical trial investigators face when patients go missing during a clinical trial. That's why we provide a comprehensive solution to mitigate the risks associated with patient lost-to-follow-up. Our dedicated team of experienced investigators uses innovative techniques and cutting-edge technology to locate missing clinical trial patients worldwide.
OmniTrace conducts research of publicly available records and databases to identify current contact information or vital status data on subjects who are Lost to Follow-Up or have withdrawn consent. This simple, crucial function significantly reduces missing data that may bias in study results and hinder the regulatory process.
OmniTrace’s services are available in over fifty countries.
OmniTrace provides comprehensive project support including ICF language review, LTM/CRA/Site LTFU training, IRB and EC response and rebuttals, death certificate retrieval, MAE monitoring, EDC assistance, Site communication, metrics development as well as other custom services.
OmniTrace supported our first study in 2003, and since have successfully handled over twenty-five thousand Lost to Follow-Up related requests globally. OmniTrace is the world’s premier providers of LTFU services.” To “OmniTrace supported our first study in 2003, and since have successfully handled over twenty-five thousand Lost to Follow-Up related requests globally. OmniTrace is the world’s premier provider of LTFU services.
OmniTrace’s clients consist of Pharmaceutical Companies, CROs, AROs, Hospitals, clinical trial sites and government agencies such as the National Institutes of Health.
For USA searches average turnaround time is 24 – 48 hours. Global searches will vary by country and may range from 7-21 days.
OmniTrace conducts legal and permissible research of publicly available records and databases where local regulations allow and when appropriate patient consent has been obtained.
A large pharmaceutical company conducted a randomized, open label, blinded-endpoint parallel group study to investigate if a particular drug has a lower incident of GI Events than other similar drugs in subjects with osteoarthritis.
Goal: Retrieve patient contact information from each site, locate the current contact information and return information to the site.
Total LTFU Subjects: 443
Number of Sites: 208
Result: OmniTrace was successful in locating 91% of all LTFU patients.
A medium sized pharmaceutical firm conducted a 56 week phase III trial to access the safety and efficiency of an obesity treatment program.
Goal: Retrieve patient contact information from each site, locate the current contact information and return it to the site. If a patient was deceased we were to provide their date of death and the resource of such data. Additionally, we were to attempt to obtain a death certificate for each subject. If the subject was alive, we were to provide the most recent “alive as of” date.
Total Subjects: 416
Number of sites: 87
Result: OmniTrace successfully determined the vital status for 99% of the subjects provided.
A leading university research hospital conducted a small endocrinology study across a limited group of subjects.
Goal: Work directly with hospital study coordinator to receive patient information, update the information and return directly to the coordinator.
Total Subjects: 47
Results: OmniTrace successfully located 44 of the 47 subjects.
A large European based pharmaceutical firm conducted a parallel, randomized, controlled evaluation cardiovascular study in 27 countries.
Goal: Retrieve subject information directly from the sites and conduct a vital status search for each subject.
Total Subjects: 47
Number of Sites: 21
Result: OmniTrace successfully determined the vital status for 92% of subjects.
Hi, Dave, I just wanted to pass on what an amazing employee you have in Ms. Ashley Watkins. She has been with me since the beginning (since 2013) and has ALWAYS been right on top of everything. I can consistently rely on her to be responsive, timely, and supportive with any of our needs. Please be sure to recognize what a fabulous employee you have. Thank you.
Connecticut – Clinical Trial Manager
In a landmark decision, the U.S. Food and Drug Administration approved XXXXXX as a first-of-its-kind treatment. This achievement is as much yours as it is ours since we could not have reached this critical milestone without the hard work and contributions of all of our vendor partners. Together we attained something that is truly amazing for patients; this represents just the beginning of more remarkable accomplishments that we anticipate moving forward for patients worldwide.
California – Sr. Director, Clinical Operations
Experienced and effective global provider of Lost to Follow-Up clinical trial support services